RT Book, Section
A1 Marlow, Mariel
A2 Boulton, Matthew L.
A2 Wallace, Robert B.
SR Print(0)
ID 1182675608
T1 Mumps
T2 Maxcy-Rosenau-Last Public Health & Preventive Medicine, 16e
YR 2022
FD 2022
PB McGraw Hill
PP New York, NY
SN 9781259644511
LK accessmedicine.mhmedical.com/content.aspx?aid=1182675608
RD 2024/04/19
AB Mumps  disease  was  described  in  the  literature  as  early  as  fifth  century  BC  by  Hippocrates.  The  etiologic  agent  was  identified  as  a  virus  in  1934  by  Johnson  and  Goodpasture  who  demonstrated  transmission  to  rhesus  monkeys1;  propagation  of  the  virus  ultimately  led  to  the  development  of  vaccines  by  the  late  1960s.2  Mumps  vaccine  has  resulted  in  dramatic  decreases  in  the  incidence  and  associated  morbidity  in  the  United  States  and  in  other  countries  that  have  introduced  the  vaccine  in  their  routine  childhood  immunization  programs.  However,  starting  in  the  mid-2000s,  mumps  epidemics  have  occurred  in  countries  with  high  mumps  vaccination  coverage,  with  the  majority  of  cases  occurring  among  persons  who  previously  received  two  doses  of  mumps  vaccine.3-7  Still,  incidence  remains  much  higher  in  countries  where  there  is  no  routine  vaccination  for  mumps.8